bf/NYSE:DNA_icon.jpeg

NYSE:DNA

Ginkgo Bioworks Holdings, Inc.

  • Stock

USD

Last Close

0.34

26/07 20:00

Market Cap

725.64M

Beta: 0.89

Volume Today

42.96M

Avg: 18.92M

PE Ratio

−2.78

PFCF: −6.38

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, ...Show More

peer of

Earnings per Share (Estimate*)

-0.4-0.3-0.2-0.12001-03-312020-09-302021-09-202022-05-162023-03-012023-11-08

Revenue (Estimate*)

50M100M150M2001-03-312020-09-302021-09-202022-05-162023-03-012023-11-08

*Estimate based on analyst consensus